| pubmed-article:3125512 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3125512 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:3125512 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
| pubmed-article:3125512 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:3125512 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:3125512 | pubmed:dateCreated | 1988-3-30 | lld:pubmed |
| pubmed-article:3125512 | pubmed:abstractText | Four anti-T lymphocyte monoclonal antibodies were produced by the hybridoma technique. Percentages of miscellaneous labelled cell suspensions, as profiles of fluorescent histograms, showed a reactivity of these 4 reagents quite comparable to that observed with anti-CD3 monoclonal antibodies. Labelling summation studies, cell-sorting studies and blocking experiments gave similar results as gave other anti-CD3 reagents. Biochemical study and functional tests: modulation effects and mitogenic properties, argued for the belonging of these 4 antibodies to the CD3 cluster. The actual data concerning the CD3 molecule are briefly resumed to underline the interest of such antibodies in the understanding of T-lymphocyte activation mechanisms during the immune response. | lld:pubmed |
| pubmed-article:3125512 | pubmed:language | fre | lld:pubmed |
| pubmed-article:3125512 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3125512 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3125512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3125512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3125512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3125512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3125512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3125512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3125512 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3125512 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3125512 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:3125512 | pubmed:issn | 0369-8114 | lld:pubmed |
| pubmed-article:3125512 | pubmed:author | pubmed-author:GenetetBB | lld:pubmed |
| pubmed-article:3125512 | pubmed:author | pubmed-author:GenetetNN | lld:pubmed |
| pubmed-article:3125512 | pubmed:author | pubmed-author:BourelDD | lld:pubmed |
| pubmed-article:3125512 | pubmed:author | pubmed-author:MerdrignacGG | lld:pubmed |
| pubmed-article:3125512 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3125512 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:3125512 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3125512 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3125512 | pubmed:pagination | 1285-91 | lld:pubmed |
| pubmed-article:3125512 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:meshHeading | pubmed-meshheading:3125512-... | lld:pubmed |
| pubmed-article:3125512 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3125512 | pubmed:articleTitle | [Anti-CD3 monoclonal antibodies. Characterization and function]. | lld:pubmed |
| pubmed-article:3125512 | pubmed:affiliation | Centre Régionale de Transfusion Sanguine, Rennes, France. | lld:pubmed |
| pubmed-article:3125512 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3125512 | pubmed:publicationType | English Abstract | lld:pubmed |
